4DMedical Limited (ASX:4DX) Launches Share Purchase Plan
4DMedical Limited (ASX:4DX) launches a Share Purchase Plan, enabling shareholders to buy up to $30,000 in new shares without fees.
Tag: Corporate Strategy & Guidance
Telix Pharmaceuticals Limited (ASX:TLX) Changes Reporting Currency to USD
Telix Pharmaceuticals Limited (ASX:TLX) will change its reporting currency from AUD to USD effective 1 January 2025, aligning financial reports with its US-based operations.
Viva Energy (ASX:VEA) Announces FY2024 Financial Results
Viva Energy (ASX:VEA) reports a 5% EBITDA increase in FY2024, driven by strategic acquisitions and strong operational performance.
AuMEGA Metals (ASX:AAM) Commences Winter Drill Program at Bunker Hill
AuMEGA Metals (ASX:AAM) commences its 2025 winter drill program at Bunker Hill, targeting high-grade copper, silver, and gold resources.
A1 Investments & Resources Ltd (ASX:AYI) Reports H1 Financial Results
A1 Investments & Resources Ltd (ASX:AYI) reports a significant decline in revenue and reduced losses for the half-year ended December 2023, with no dividends declared.
Noxopharm Limited (ASX:NOX) Reports FY2025 Half Year Results
Noxopharm Limited (ASX:NOX) reports a 50.5% reduction in half-year losses and advances its clinical trials and strategic partnerships.
Viking Mines Limited (ASX:VKA) Reports Promising 2nd Regional Drill Results
Viking Mines (ASX:VKA) announces significant gold intercepts across 1.7km at Bifrost Target, outlining aggressive future drilling plans.
XPON Technologies Group Ltd (ASX:XPN) Announces H1 FY25 Results
XPON Technologies Group (ASX:XPN) announces H1 FY25 results, highlighting operational achievements and improved financial performance.
Eildon Capital Group (ASX:EDC) Reports Half Year 2025 Results
Eildon Capital Group (ASX:EDC) reports a net loss after adjustments in HY25, highlighting key operational achievements and strategic initiatives.
AVA Risk Group Limited (ASX:AVA) Reports H1 FY2025 Financial Results
AVA Risk Group Limited (ASX:AVA) reports a 20% revenue increase and significant EBITDA improvement in H1 FY2025, driven by its Detect segment.